4//SEC Filing
Ajer Jeffrey Robert 4
Accession 0001048477-23-000039
CIK 0001048477other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 3:57 PM ET
Size
6.3 KB
Accession
0001048477-23-000039
Insider Transaction Report
Form 4
Ajer Jeffrey Robert
SVP, Chief Commercial Of
Transactions
- Award
Common Stock
2023-04-28$66.88/sh+318$21,267→ 65,804 total - Sale
Common Stock
2023-08-16$90.00/sh−5,000$450,000→ 60,804 total
Footnotes (2)
- [F1]Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan.
- [F2]Trade made pursuant to a 10b5-1 plan executed on April 13, 2023.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0001557533
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 3:57 PM ET
- Size
- 6.3 KB